Blog

China’s Zhixiang – A Global Pharmaceutical Industry

In 1978, if anyone had been told that within 40 years Maoist-oriented China would be rapidly gaining on the United States as having the largest economy in the world, you would have been labelled delusional, if not totally…


China’s Regulatory Mosaic: The Troops Have Their Marching Orders

China’s State Council has announced to its people and to the world that the second largest drug market will become a world leader in pharmaceutical innovation, commercialization and manufacturing. Simply put, China will no longer rely on research-based…


China’s Drug Industry Reforms: Is the Mosaic Finally Coming Together for Western Pharma?

A note from author David Deere: To foster a global and innovative pharmaceutical industry and reduce the disproportional healthcare costs attributable to drugs, the Chinese government has formally targeted the industry for economic development. To facilitate these objectives,…


Chinese Drug Reform and the Knights Templar: Symbolism or Coincidence?

A David Deere Advisory Alert Nine centuries ago, wealthy Christians often made pilgrimages from Europe to Jerusalem, among the most sacred places in the Holy Land. It was, to say the least, an arduous and dangerous journey. In…


Trump Has Bone to Pick with Big Pharma – and It’s Not About R&D

Like a dog with an odorous bone, President Donald Trump just won’t let go of his plan to bring down drug prices in America. Tweeting about it on Tuesday, he said: “I am working on a new system…


Trump’s Promised Medicare/Medicaid Reforms Pose an Existential Threat Big Pharma’s Business Model

President Trump, hate him, love, him or just entertained by him; could not have been clearer about his intentions on drug pricing. Much to the chagrin of the pharmaceutical industry, drug prices are going to come down. Quickly….


The Year of the Fire Rooster Sets the Stage for China-US Relations

“Always higher, always going on.” – Motto of the Chinese Zodiac’s Rooster It seems appropriate that China’s 2017 New Year is the year of the Red Fire Rooster. The tenth Chinese zodiac sign, the Rooster is known for…


Update on CFDA’s Fast-Track Approval: 7 MNC Products Move to Data Inspection Stage

It’s been a little more than a year since China’s FDA (CFDA) announced sweeping policy changes intended to streamline the review of innovative new drugs and rid their system of subpar applicants blocking the progress of true candidates…


The Trump Effect on U.S.-China Relations

Helen Wang, an award-winning author and expert on China’s middle class, recently penned the following article for Forbes on what President-Elect Trump’s presidency signals for the future of United States-China trade relations. We are sharing it now with…


China’s Pharmaceutical “Sea Turtles” – Innovation or Imitation and Does It Matter?

During a discussion about the future direction of immuno-oncology pharmaceuticals at the Annual ChinaBio® Partnering Meeting held in Suzhou, China, last May, one point of disagreement among the panelists was whether the number of Chinese companies targeting development…